Low tacrolimus dose requirements in renal transplant recipients in the Omani population: Implications for pharmacogenetics?

Transplantation Proceedings

Volumn 37, Issue 7, 2005, Pages 2911-2912

  Mohsin, N ^a   Pakkyara, A ^a   Budruddin, M ^a   Obaid, F ^a   Kumar, A ^a   Malvathu, S ^a   Kalankara, S ^a   Amitabh, A ^a   Daar, A ^a  

^a ROYAL HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; BODY WEIGHT; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; GENETIC POLYMORPHISM; GINGIVA HYPERTROPHY; GRAFT REJECTION; HIRSUTISM; HUMAN; HYPERTENSION; KIDNEY GRAFT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PHARMACOGENOMICS; PNEUMONIA; PRIORITY JOURNAL; SAMPLE SIZE;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; OMAN; PHARMACOGENETICS; TACROLIMUS;

EID: 26444618646     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.07.027     Document Type: Article

References (5)

1. W.M. Brent, D.C. Brennan Maintenance immunosuppressive therapy in renal transplantation UpToDate 12 2004 1
2. J.F. Neylan FK506 Kidney Transplant Study Group Racial differences in renal transplantation after immunosuppression with tacrolimus versus Cyclosporine Transplantation 65 1998 515
3. D.M. Stefan Pharmacology and side effects of Cyclosporine and tacrolimus UpToDate 12 2004 1
4. D. Aglicheau, C. Verstuyft, P. Laurent-Puig Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients J Am Soc Nephrol 14 2003 1889
5. J.M. Lehmann, D.D. McKee, M.A. Watson The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J Clin Invest 102 1998 1016